News Sentiment

NUVB sentiment intelligence

Nuvation Bio Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 66 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 5.81 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 57

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+1.9% over one week, +18.1% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Nuvation Bio’s Global Strategy

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction 1.9% Price digesting
Trend fit Trend inactive 18.1% over four weeks
Fair value 83.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 44
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 57
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
Stock Titan 9
simplywall.st 8
Investing.com 7
TradingView 4
MT Newswires 3
PR Newswire 3
Simply Wall Street 2

Event Lens

What the news is about

Classified themes
Market update 36
Earnings 20
Regulatory and legal 4
Analyst action 3
Deals and strategy 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 66
Pharmaceutical Executive Direct company coverage

Nuvation Bio’s Global Strategy

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 10:03
Source
Pharmaceutical Executive
timothysykes.com Direct company coverage

Nuvation Bio Inc. Class A (NUVB) Stock Price | Live Quotes & Charts | NYSE

This page provides live quotes and charts for Nuvation Bio Inc. Class A (NUVB) stock, showing its current price of $6.11, an increase of $0.24 (4.09%). It indicates that analyst ratings and earnings information for NUVB are not currently available. The page also includes disclaim

Tone
Positive 61/100
Event
Earnings
Published
10 Jul 2026 00:40
Source
timothysykes.com
Market source Direct company coverage

Nuvation Bio Inc. Announces Full Exercise of Greenshoe Option in $287.5 Million Convertible Senior Notes Offering

Nuvation Bio Inc. announced that the underwriters have fully exercised their over-allotment option, or "Greenshoe Exercise," to purchase an additional $37.5 million of its 0.75% Convertible Senior Notes due 2032. This brings the total offering to $287.5 million. The net proceeds,

Tone
Positive 63/100
Event
Market update
Published
06 Jul 2026 21:13
Source
Market source
TradingView Direct company coverage

Total common shares outstanding of Nuvation Bio, Inc. Class A – FWB:1E30

This article provides details on the total common shares outstanding for Nuvation Bio, Inc. Class A, traded on the Frankfurt Stock Exchange under the ticker FWB:1E30. It indicates that the market was closed with no trades when the information was accessed. The page also features

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 05:10
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Nuvation Bio, Inc. Class A – FWB:1E30

This article provides financial information for Nuvation Bio, Inc. Class A (FWB:1E30) on the Frankfurt Stock Exchange. It specifically highlights the "Price to earnings forward" metric for the company. The page appears to be a financial data presentation without detailed analysis

Tone
Neutral 50/100
Event
Earnings
Published
03 Jul 2026 19:40
Source
TradingView
TradingView Direct company coverage

ETFs Investing in Nuvation Bio, Inc. Class A Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Nuvation Bio, Inc. Class A stocks, providing details such as market value, weight, issuer, management style, expense ratio, AUM, price, and 3-year NAV total return. The ETFs cover different investment focuses inclu

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 17:09
Source
TradingView
TradingView Direct company coverage

Nuvation Bio, Inc. Class A Actuals & Estimates (NYSE:NUVB)

This article provides an overview of Nuvation Bio Inc. (NYSE: NUVB) stock performance, financial estimates, and analyst forecasts. It covers key metrics like current stock price, historical highs and lows, market capitalization, volatility, and details on past and upcoming earnin

Tone
Positive 63/100
Event
Analyst action
Published
26 Jun 2026 13:40
Source
TradingView
PR Newswire Direct company coverage

Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes

Nuvation Bio Inc. has announced the pricing of an upsized underwritten offering of $250.0 million in 0.75% Convertible Senior Notes due in 2032. The net proceeds, estimated at approximately $241.2 million, will be used to pay for capped call transactions, repay a senior secured l

Tone
Positive 64/100
Event
Market update
Published
26 Jun 2026 04:10
Source
PR Newswire
Investing News Network Direct company coverage

Nuvation Bio Announces Proposed Convertible Senior Notes Offering

Nuvation Bio Inc. announced its intent to offer $200.0 million in Convertible Senior Notes due in 2032, with an option for underwriters to purchase an additional $30.0 million. The company plans to use the proceeds to cover capped call transactions, repay its senior secured loan,

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 03:10
Source
Investing News Network
Investing.com Direct company coverage

Nuvation Bio’s chief people officer sells $753k in stock

Nuvation Bio's Chief People Officer, Markel Stacy, sold 125,000 shares of Class A Common Stock for $753,187, following the exercise of stock options. This sale was part of a pre-arranged trading plan, occurring after the company's stock surged 215% over the past year. Nuvation Bi

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 23:10
Source
Investing.com
Investing.com Direct company coverage

Nuvation Bio prices $250M convertible notes offering

Nuvation Bio Inc. has priced an upsized offering of $250 million in convertible senior notes due in 2032, increasing from a previously announced $200 million. The biotech company will use the proceeds to pay for capped call transactions, repay its existing senior secured loan of

Tone
Positive 64/100
Event
Market update
Published
25 Jun 2026 21:09
Source
Investing.com
Investing.com Direct company coverage

Nuvation Bio CFO Sauvage sells $286k in stock

Nuvation Bio's CFO, Philippe Sauvage, sold 47,668 shares of Class A Common Stock for $286,370 on June 23, 2026, as part of a pre-arranged trading plan. This transaction occurred after he exercised stock options to acquire the shares. Following the sale, Sauvage holds 12,673 direc

Tone
Negative 39/100
Event
Market update
Published
25 Jun 2026 13:40
Source
Investing.com
Investing.com Australia Direct company coverage

Nuvation Bio CFO Sauvage sells $286k in stock By Investing.com

Nuvation Bio Inc.'s CFO, Philippe Sauvage, sold 47,668 shares of Class A Common Stock for $286,370 on June 23, 2026, as part of a pre-arranged trading plan, after exercising stock options. Despite a significant stock surge, InvestingPro suggests the shares might be overvalued. Th

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 05:10
Source
Investing.com Australia
Investing.com Direct company coverage

Nuvation Bio chief regulatory officer sells $379k in stock

Kerry Wentworth, Chief Regulatory Officer at Nuvation Bio Inc. (NASDAQ:NUVB), sold 63,000 shares of company stock worth $379,190 on June 23, 2026, following the exercise of stock options. This sale was conducted under a 10b5-1 trading plan and comes after a significant 215% surge

Tone
Neutral 50/100
Event
Regulatory and legal
Published
24 Jun 2026 23:10
Source
Investing.com